Inventory Turnover (Annual)

Inventory Turnover: A ratio showing how many times a company's inventory is sold and replaced over a period. Calculated as: Cost of Goods Sold / Total Inventory

HCW Biologics Inc. (HCWB) Inventory Turnover data is not available.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$2.84M
Net Income	$-24.99M
Cost of Goods Sold	$2.28M
Gross Profit	$0.56M
Operating Expenses	$28.56M
Operating Income	$-25.72M
Non-Operating Income/Expense	$0.72M
Pre-Tax Income	$-24.99M
Normalized Pre-Tax Income	$-24.99M
Income after Taxes	$-24.99M
Income from Continuous Operations	$-24.99M
Consolidated Net Income/Loss	$-24.99M
Normalized Income after Taxes	$-24.99M
EBIT	$-25.72M
EBITDA	$-24.58M
Weighted-Average Shares Outstanding (Basic)	35.93M
Weighted-Average Shares Outstanding (Diluted)	35.93M
Earnings per Share (EPS) (Basic)	$-0.70
Earnings per Share (EPS) (Diluted)	$-0.70
Balance Sheet Financials
Current Assets	$6.40M
Property, Plant, and Equipment	$20.45M
Long-Term Assets	$22.11M
Total Assets	$28.51M
Current Liabilities	$8.75M
Long-Term Debt	$6.30M
Long-Term Liabilities	$6.30M
Total Liabilities	$15.05M
Common Equity	$13.46M
Tangible Shareholders Equity	$13.46M
Shareholders Equity	$13.46M
Common Shares Outstanding	36.02M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-22.51M
Cash Flow from Investing Activities	$3.80M
Cash Flow from Financial Activities	$-0.01M
Beginning Cash	$22.33M
End Cash	$3.60M
Increase/Decrease in Cash	$-18.73M
Stock-Based Compensation	$1.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.73
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.47
Gross Margin	19.72%
Operating Margin	-904.96%
EBIT Margin	-904.96%
EBITDA Margin	-865.02%
Pre-Tax Profit Margin	-879.52%
Profit Margin	-879.52%
Free Cash Flow	$-28.72M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	--
Receiveable Turnover	1.85
Days Sales in Receivables	197.25
Return on Equity	-185.67%
Return on Tangible Equity	-185.67%
Return on Assets	-87.66%
Return on Investments	-126.45%
Book Value Per Share	$0.37
Free Cash Flow per Share	$-0.80
Operating Cash Flow per Share	$-0.63

Data from Zacks Investment Research, Inc.